{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:30:57Z","timestamp":1792373457300,"version":"4.4.0"},"reference-count":26,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2000,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:italic>Salmonella enterica<\/jats:italic>serovar Typhi strain CVD 908-<jats:italic>htrA<\/jats:italic>is a live attenuated strain which may be useful as an improved oral typhoid vaccine and as a vector for cloned genes of other pathogens. We conducted a phase 2 trial in which 80 healthy adults received one of two dosage levels of CVD 908-<jats:italic>htrA<\/jats:italic>in a double-blind, placebo-controlled, crossover study. There were no differences in the rates of side effects among volunteers who received high-dose vaccine (4.5 \u00d7 10<jats:sup>8<\/jats:sup>CFU), lower-dose vaccine (5 \u00d7 10<jats:sup>7<\/jats:sup>CFU), or placebo in the 21 days after vaccination, although recipients of high-dose vaccine (8%) had more frequent diarrhea than placebo recipients (0%) in the first 7 days. Seventy-seven percent and 46% of recipients of high- and lower-dose vaccines, respectively, briefly excreted vaccine organisms in their stools. All blood cultures were negative. Antibody-secreting cells producing antilipopolysaccharide (LPS) immunoglobulin A (IgA) were detected in 100 and 92% of recipients of high- and lower-dose vaccines, respectively. Almost half the volunteers developed serum anti-LPS IgG. Lymphocyte proliferation and gamma interferon production against serovar Typhi antigens occurred in a significant proportion of vaccinees. This phase 2 study supports the further development of CVD 908-<jats:italic>htrA<\/jats:italic>as a single-dose vaccine against typhoid fever and as a possible live vector for oral delivery of other vaccine antigens.<\/jats:p>","DOI":"10.1128\/iai.68.3.1196-1201.2000","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:03:59Z","timestamp":1027764239000},"page":"1196-1201","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":154,"title":["Phase 2 Clinical Trial of Attenuated<i>Salmonella enterica<\/i>Serovar Typhi Oral Live Vector Vaccine CVD 908-<i>htrA<\/i>in U.S. Volunteers"],"prefix":"10.1128","volume":"68","author":[{"given":"Carol O.","family":"Tacket","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, Department of Medicine, University of Maryland School of Medicine, Baltimore,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo B.","family":"Sztein","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, Department of Medicine, University of Maryland School of Medicine, Baltimore,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S.","family":"Wasserman","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, Department of Medicine, University of Maryland School of Medicine, Baltimore,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Losonsky","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, Department of Medicine, University of Maryland School of Medicine, Baltimore,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Kotloff","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, Department of Medicine, University of Maryland School of Medicine, Baltimore,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Wyant","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, Department of Medicine, University of Maryland School of Medicine, Baltimore,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Nataro","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, Department of Medicine, University of Maryland School of Medicine, Baltimore,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Edelman","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, Department of Medicine, University of Maryland School of Medicine, Baltimore,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Perry","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->University of Maryland, College Park, University Health Center, College Park,2 Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bedford","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Peptide Therapeutics Group plc, Cambridge,3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brown","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Evans Medical Limited, Liverpool,4 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Chatfield","sequence":"additional","affiliation":[{"name":"<!--label omitted: 5-->Medeva Group Research5 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Dougan","sequence":"additional","affiliation":[{"name":"<!--label omitted: 6-->Imperial College of Science, Technology, and Medicine,6 London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron M.","family":"Levine","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Vaccine Development, Department of Medicine, University of Maryland School of Medicine, Baltimore,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198710293171801"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.10.4172-4181.1996"},{"key":"e_1_3_2_4_2","first-page":"9","article-title":"Immunogenicity of Ty21a attenuated Salmonella typhi given with sodium bicarbonate or in enteric-coated capsules","volume":"53","author":"Black R.","year":"1983","unstructured":"Black R. Levine M. M. Young C. Rooney J. Levine S. Clements M. L. O'Donnell S. Hughes T. Germanier R. Chilean Typhoid Committee Immunogenicity of Ty21a attenuated Salmonella typhi given with sodium bicarbonate or in enteric-coated capsules.Dev. Biol. Stand.531983914","journal-title":"Dev. Biol. Stand."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.1.86"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0882-4010(92)90117-7"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00227-7"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/131.5.553"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00003-J"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.4.927"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/291238a0"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1991.tb02122.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.47.3.605-612.1985"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91316-X"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112899"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/133.4.424"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.Supplement_3.S552"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.2.700-707.1999"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1999.4733"},{"key":"e_1_3_2_20_2","first-page":"59","article-title":"Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves","volume":"45","author":"Smith B. P.","year":"1984","unstructured":"Smith B. P. Reina-Guerra M. Hoiseth S. K. Stocker B. A. D. Habasha F. Johnson E. Merritt F. Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves.Am. J. Vet. Res.4519845966","journal-title":"Am. J. Vet. Res."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.4049\/jimmunol.155.8.3987","article-title":"Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans","volume":"155","author":"Sztein M. B.","year":"1995","unstructured":"Sztein M. B. Tanner M. K. Polotsky Y. Orenstein J. M. Levine M. M. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans.J. Immunol.155199539873993","journal-title":"J. Immunol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.6.1508"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.6.1620-1627.1990"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.2.536-541.1992"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(92)90392-W"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.8.3381-3385.1997"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.2.452-456.1997"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.68.3.1196-1201.2000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.68.3.1196-1201.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:44:23Z","timestamp":1682264663000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.68.3.1196-1201.2000"}},"subtitle":[],"editor":[{"given":"J. D.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1128\/IAI.68.3.1196-1201.2000"],"URL":"https:\/\/doi.org\/10.1128\/iai.68.3.1196-1201.2000","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]},"assertion":[{"value":"1999-09-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-11-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}